David Chang

Chief Executive Officer • WuXi Advanced Therapies

Dr. David Chang, Chief Executive Officer at WuXi Advanced Therapies and OXGENE, holds a wealth of experience in the cell and gene therapy industry, including biopharmaceutical technical development, manufacturing operations, engineering, and strategy. Prior to joining WuXi Advanced Therapies, David held the role of Corporate Vice President and Head of Cell Therapy Global Manufacturing at Celgene Corporation, a Bristol-Myers Squibb Company, where he oversaw the global CAR-T manufacturing network and technologies. David earned a bachelor’s in chemical engineering from National Taiwan University and holds a Ph.D. in biochemical engineering from the Massachusetts Institute of Technology.

Also Speaking

Karen Moniz

Technical Director • ICCBBA

Andreas Kouri

Senior Vice President, Supply Chain Strategic Operations • ElevateBio

Hanna Lesch

Chief Technology Officer • Exothera

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.